Fast Five Quiz: Eosinophilic Asthma

Zab Mosenifar, MD

March 17, 2023

According to the GINA report "Global Strategy for Asthma Management and Prevention," higher blood eosinophils is a strong predictor of a good response to targeted biologic therapy. Add-on biologics that target interleukin (IL-5, IL-5R, and IL-4) receptors are approved for use in different age groups by subcutaneous injection. The same GINA report provides specific guidance on eligibility and dosing.

Learn more about treatment recommendations for EA.

Editor's Recommendations

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Zab Mosenifar. Fast Five Quiz: Eosinophilic Asthma - Medscape - Mar 17, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Fast Five Quiz: Eosinophilic Asthma

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Zab Mosenifar, MD

Comments

Email This

Feedback